Bristol Myers Squibb (BMY) Shares Repurchased (2010 - 2023)

Bristol Myers Squibb (BMY) has 12 years of Shares Repurchased data on file, last reported at $4.0 billion in Q3 2023.

• Shares Repurchased for Q3 2023 came in at $4.0 billion, up 470.61% year-over-year; the trailing twelve-month figure through Jun 2024 was $4.0 billion (down 6.37% YoY), and the FY2023 annual result was $5.2 billion, down 35.57% from the prior year.
• Shares Repurchased grew to $4.0 billion in Q3 2023 per BMY's latest filing, from $905.0 million in the prior quarter.
• Over five years, Shares Repurchased peaked at $7.0 billion in Q4 2019 and troughed at $81.0 million in Q1 2020.
• A 5-year average of $2.0 billion and a median of $1.4 billion in 2020 frame the typical range for Shares Repurchased.
• The sharpest annual moves came in 2021 and 2023: Shares Repurchased jumped 2091.36% in 2021, then sank 95.0% in 2023.
• A 5-year view of Shares Repurchased shows it stood at $7.0 billion in 2019, then plunged by 79.07% to $1.5 billion in 2020, then soared by 87.78% to $2.8 billion in 2021, then dropped by 12.18% to $2.4 billion in 2022, then soared by 65.56% to $4.0 billion in 2023.
• Business Quant data shows BMY's Shares Repurchased at $4.0 billion in Q3 2023, $905.0 million in Q2 2023, and $250.0 million in Q1 2023.